-+ 0.00%
-+ 0.00%
-+ 0.00%

Ligand CLO, Secretary Andrew Reardon sells USD 1.43 million in common shares

PUBT·09/08/2026 22:34:45
Listen to the news
Ligand CLO, Secretary Andrew Reardon sells USD 1.43 million in common shares
  • Ligand Pharmaceuticals CLO and Secretary Andrew Reardon sold 5,000 shares on Sept. 3.
  • Sales priced at about $283.99 to $288.98 per share.
  • Directly held stake fell to 36,514 shares after the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ligand Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002001011-26-000137), on September 08, 2026, and is solely responsible for the information contained therein.